Z Squared Inc. Files S-1 for Resale of 41.6M Shares
Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.) has filed a Form S-1 registration statement with the SEC on June 9, 2026. This filing pertains to the potential resale of up to 41,584,562 shares of common stock by designated selling securityholders. These shares constitute a significant portion, approximately 80.85%, of the company's outstanding stock as of June 8, 2026. The shares were primarily acquired by former members of BSG Series CM, LLC following a business combination. Substantial lock-up and leak-out restrictions are in place, set to expire on October 27, 2027, though they may be terminated earlier under certain conditions. The company's common stock is listed on the Nasdaq Global Market under the ticker symbol 'ZSQR'.
Key Highlights
- Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.) filed an S-1 registration statement on June 9, 2026.
- The filing relates to the resale of up to 41,584,562 shares of common stock by selling securityholders.
- These shares represent approximately 80.85% of the Company's outstanding common stock as of June 8, 2026.
- The shares were received by former members of BSG Series CM, LLC in connection with a business combination.
- Lock-up and leak-out restrictions on these shares expire on October 27, 2027, subject to earlier termination.
- The Company's common stock trades on the Nasdaq Global Market under the symbol 'ZSQR'.